Submitted:
05 January 2024
Posted:
08 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
Statistics
3. Results
3.1. Presentation
3.2. Surgical findings
3.3. Surgical technique
3.4. Outcome
3.5. Long term results
3.6. Factors related to malnutrition
4. Discussion
Author Contributions
Institutional Review Board Statement
Conflicts of Interest
References
- Sánchez-Pernaute A, Rubio Herrera MA, Pérez-Aguirre E, García Pérez JC, Cabrerizo L, Díez Valladares L, Fernández C, Talavera P, Torres A. Proximal duodenal-ideal end-to-side bypass with sleeve gastrectomy: proposed technique. Obes Surg 2007, 17, 1614-1618. [CrossRef]
- Sánchez-Pernaute A, Rubio MA, Pérez Aguirre E, Barabash A, Cabrerizo L, Torres A. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg Obes Relat Dis 2013, 9, 731–735. [Google Scholar] [CrossRef] [PubMed]
- Gagner, M. Hypoabsorption not malabsorption, hypoabsorptive surgery and not malabsorptive surgery. Obes Surg 2016, 26, 2783–2784. [Google Scholar] [CrossRef] [PubMed]
- Vilallonga R, Balibrea JM, Curell A, Gonzalez O, Caubet E, Ciudin A, Ortiz-Zúñiga AM, Fort JM. Technical options for malabsorption issues after single anastomosis duodenoileal bypass with sleeve gastrectomy. Obes Surg 2017, 27, 3344–3348. [Google Scholar] [CrossRef] [PubMed]
- Sánchez-Pernaute A, Rubio Herrera MA, Pérez Ferré N, Sáez Rodríguez C, Marcuello C, Pañella C, López Antoñanzas L, Torres A, Pérez-Aguirre E. Long-term results of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Obes Surg 2022, 32, 682–689. [Google Scholar] [CrossRef] [PubMed]
- Wagner M, Mayer BFB, Bodenstedt S, Kowalewski K, Nickel F, Speidel S, Fischer L, Kenngott HG, Müller-Stich B. Comparison of conventional methods for bowel length measurement in laparoscopic surgery to a novel computer-assisted 3D measurement system. Obes Surg 2021, 31, 4692–4700. [Google Scholar] [CrossRef] [PubMed]
- Slagter N, van Wilsum M, de Heide LJM, Jutte EH, Kaiser MA, Damen SL, van Beek AP, Emous M. Laparoscopic small vowel length measurement in bariatric surgery using a hand-over-hand technique with marked graspers: an ex vivo experiment. Obes Surg 2022, 32, 1201–1208. [Google Scholar] [CrossRef]
- Karagül S, Kayaalp C. Repeated stretched or non-stretched small bowel length measurements in healthy individuals. Turk J Surg 2019, 35, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Cossu ML, Fais E, Meloni GB, Profili S, Masala A, Alagna S, Rovasio PP, Spartà C, Pilo L, Tilocca PL, Noya G. Impact of age on long-term complications after biliopancreatic diversion. Obes Surg 2004, 14, 1182–1186. [Google Scholar] [CrossRef]
- Carvalho J, Correia MA, Kanegusuku H, Longano P, Wolosker N, Ritti-Dias RM, Cucato GG. Association between the risk of malnutrition and functional capacity in patients with peripheral arterial disease: a cross-sectional study. PLoS ONE 2022, 17, e0273051. [CrossRef]
- Vespasiani-Gentilucci U, Vorini F, Carotti S, De Vincentis A, Galati G, Gallo P, Scopinaro N, Picardi A. Hepatic complications of bariatric surgery: the reverse side of the coin. Acta Gastroenterol Belg 2017, 80, 505–513. [Google Scholar]
- Prakash G, Drenick EJ, Wexler H, Delucia L, Finegold SM. Microbial flora in the bypassed jejunum of patients with biliopancreatic bypass for obesity. Am J Clin Nutr 1987, 46, 273–276. [Google Scholar] [CrossRef] [PubMed]
- Kirkpatrick V, Moon RC, Teixeira AF, Jawad MA. Cirrhosis following single anastomosis duodeno-ileal switch: a case report. Int J Surg Case Rep 2018, 45, 130–132. [Google Scholar] [CrossRef]
- Addeo P, Cesaretti M, Anty R, Iannelli A. Liver transplantation for bariatric surgery-related liver failure: a systematic review of a rare condition. Surg Obes Relat Dis 2019, 15, 1394–1401. [Google Scholar] [CrossRef] [PubMed]



| Case nº | Limb length | Indication | Other causes | Time to Surgery | Nº admissions | Real length | Technique | Stomach |
|---|---|---|---|---|---|---|---|---|
| 1 | 200 | Diarrhea | Hypocalcemia | 65 | 5 | 200 | SADI-S 350 | Re-Sleeve |
| 2 | 200 | Malnutrition | Diarrhea | 114 | 2 | 200 | SADI-S 350 | |
| 3 | 200 | Malnutrition | 28 | 1 | 200 | RnY DS | ||
| 4 | 200 | Malnutrition | Diarrhea | 120 | 1 | 200 | SADI-S 300 | |
| 5 | 200 | Malnutrition | Aged | 28 | 2 | 200 | RnY DS | |
| 6 | 200 | Liver Failure | Alcohol | 133 | 1 | 200 | SADI-S 300 | Re-Sleeve |
| 7 | 200 | Diarrhea | 37 | 1 | 250 | SADI-S 350 | ||
| 8 | 250 | Malnutrition | 156 | 1 | 170 | SADI-S 300 | ||
| 9 | 250 | Malnutrition | 17 | 2 | 250 | RnY DS | ||
| 10 | 250 | Malnutrition | Schizophrenia | 16 | 1 | 250 | Duodeno-duodenostomy | |
| 11 | 250 | Malnutrition | 40 | 1 | 250 | SADI-S 350 | Re-Sleeve | |
| 12 | 250 | Liver Failure | Viral Hepatitis | 23 | 3 | 220 | Duodeno-jejunostomy | |
| 13 | 250 | Malnutrition | 19 | 3 | 150 | SADI-S 350 | ||
| 14 | 250 | Malnutrition | 76 | 1 | 190 | SADI-S 350 | ||
| 15 | 250 | Liver Failutre | Alcohol | 16 | 1 | 250 | SADI-S 350 | |
| 16 | 250 | Malnutrition | 20 | 1 | 200 | SADI-S 300 |
| No Malnutrition | Admission - No Reoperation | Reoperation | Non reop. vs Reop. Significance (p) | Cut off | |
|---|---|---|---|---|---|
| Male % | 36,5 % | 21,4 % | 37,5 % | 0,9 | |
| Age (years) | 46,8 (0,69) | 49,5 (3,09) | 53,5 (2,4) | 0,03 | ≥ 55 |
| BMI (kg/m2) | 46,7 (0,45) | 50,7 (2,97) | 41,5 (1,15) | 0,01 | ≤ 44 |
| Hemoglobin (g/dL) | 14,08 (0,09) | 13,1 (0,42) | 13,8 (0,42) | 0,6 | |
| Hematocrit (%) | 42,5 (0,37) | 40,7 (1,0) | 41 (1,15) | 0,36 | |
| Iron (µg/dL) | 76,1 (3,17) | 67,8 (11,3) | 79,2 (17) | 0,81 | |
| Albumin (g/dL) | 4,19 (0,01) | 3,99 (0,08) | 4,2 (0,08) | 0,3 | |
| Total Proteins (g/dL) | 7,13 (0,03) | 6,7 (0,17) | 7,2 (0,13) | 0,36 | |
| Calcium (mg/dL) | 9,48 (0,04) | 9,3 (0,13) | 9,7 (0,09) | 0,14 | |
| Glucose (mg/dL) | 131 (3,69) | 129 (13,5) | 174 (20,22) | 0,01 | ≥ 170 |
| HbA1c (%) | 6,9 (0,12) | 6,9 (0,41) | 8,81 (0,79) | 0,048 | ≥ 7,5 |
| Triglycerides (mg/dL) | 164 (6,9) | 146 (20,7) | 176 (44,1) | 0,7 | |
| HDL-Cholesterol (mg/dL) | 49,2 (1,02) | 56,3 (4,49) | 47 (2,37) | 0,4 | |
| LDL-Cholesterol (mg/dL) | 109,6 (2,73) | 106,9 (9,88) | 86,8 (11,3) | 0,08 | |
| Total Cholesterol (mg/dL) | 190 (2,7) | 194 (11,5) | 180 (12,4) | 0,4 | |
| AST (U/L) | 24 (0,9) | 17,1 (2,57) | 30,8 (5,2) | 0,11 | |
| ALT (U/L) | 28,2 (1,28) | 23,8 (5,3) | 36,9 (5,09) | 0,12 | |
| GGT (U/L) | 44 (4,02) | 54,3 (25,3) | 74,5 (36,08) | 0,11 | |
| Alkaline Phosphatase (U/L) | 83,8 (2,47) | 82,8 (8,14) | 60,4 (6,02) | 0,029 | ≤ 70 |
| T2DM | 54 % | 50 % | 75 % | 0,36 | |
| Hypertension | 50 % | 57 % | 100 % | <0,001 | |
| Obstructive Apnea | 47 % | 50 % | 50 % | 0,35 |
| Reoperated | Non Reoperated | p | |
|---|---|---|---|
| Hemoglobin (g/dL) | 12,3 | 13,4 | 0,005 |
| Hematocrit (%) | 37,4 | 40,4 | 0,004 |
| Albumin (g/dL) | 3,4 | 3,9 | 0,01 |
| Glucose (mg/dL) | 81,8 | 90 | 0,002 |
| HbA1c (%) | 4,8 | 5,2 | 0,03 |
| LDL-Cholesterol (mg/dL) | 60 | 78 | 0,01 |
| Total Cholesterol (mg/dL) | 124 | 143 | 0,02 |
| Transferrin (mg/dL) | 153 | 223 | 0,006 |
| Ferritin (ng/mL) | 305 | 120 | 0,001 |
| Gammaglutamyl transferase (U/L) | 71 | 30 | 0,001 |
| Cupper (µg/dL) | 69 | 101 | 0,007 |
| Bowel movements | 3,3 | 2,2 | 0,03 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).